Jitender Gairolla , Diksha1 , Shikha Mudgal2 , Prakamya Gupta3 , Pratima Gupta4 , Manisha Naithani5 , Yogendra Pratap Mathuria6 , Priyanka Naithani7 , Biswajeet Sahoo8 , Mankirat Kaur Sachdeva9 , Jitender Gairolla10
Diksha Rani, Jitender Gairolla, Shikha Mudgal, et. al./Corona Virus Disease-19, Obesity & Leptin: A Complex Paradigm/J Microbiol Relat Res. 2021;7(2): 65–74
The global prevalence of obesity is increasing and recognized as a potential risk factor for viral infections including Coronavirus Disease-19. Morbidity and mortality due to COVID-19 are higher in obesity which is considered a constant state of low-grade inflammatory milieu. Emerging data revealed a fatal connection of obesity with COVID-19 however the underlying mechanism is unclear. Leptin, a non-glycosylated peptide hormone derived from white adipose tissue that assists in metabolism, homeostasis, neuroendocrine, and other physiological functions. Additionally, leptin, as an adipocytokine has pro-inflammatory properties and acts as a connecting link between obesity and host immune responses thus, proliferates the secretion of C-reactive protein (CRP), IFN-γ, TNF-α IL-6, IL-4 and IL-2. This paper aims to address the paramount role of leptin as a potential mediator of inflammation that could exaggerate and worsen the prognosis of COVID-19 in obese individuals. Furthermore, the disproportionate efficacy of the COVID-19 vaccine in obese individuals is also highlighted.
No records found.
Diksha Rani, Jitender Gairolla, Shikha Mudgal, et. al./Corona Virus Disease-19, Obesity & Leptin: A Complex Paradigm/J Microbiol Relat Res. 2021;7(2): 65–74
| Received | Accepted | Published |
|---|---|---|
| N/A | N/A | N/A |
Monday 22 June 2026, 04:45:19 (IST)
Download citation
Highlight selected keywords in the article text.
| Received | N/A |
| Accepted | N/A |
| Published | N/A |